These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
273 related articles for article (PubMed ID: 24402736)
21. Cell division cycle protein 73 homolog (CDC73) mutations in the hyperparathyroidism-jaw tumor syndrome (HPT-JT) and parathyroid tumors. Newey PJ; Bowl MR; Cranston T; Thakker RV Hum Mutat; 2010 Mar; 31(3):295-307. PubMed ID: 20052758 [TBL] [Abstract][Full Text] [Related]
22. Loss of parafibromin immunoreactivity is a distinguishing feature of parathyroid carcinoma. Tan MH; Morrison C; Wang P; Yang X; Haven CJ; Zhang C; Zhao P; Tretiakova MS; Korpi-Hyovalti E; Burgess JR; Soo KC; Cheah WK; Cao B; Resau J; Morreau H; Teh BT Clin Cancer Res; 2004 Oct; 10(19):6629-37. PubMed ID: 15475453 [TBL] [Abstract][Full Text] [Related]
23. Surveillance for early detection of aggressive parathyroid disease: carcinoma and atypical adenoma in familial isolated hyperparathyroidism associated with a germline HRPT2 mutation. Kelly TG; Shattuck TM; Reyes-Mugica M; Stewart AF; Simonds WF; Udelsman R; Arnold A; Carpenter TO J Bone Miner Res; 2006 Oct; 21(10):1666-71. PubMed ID: 16995822 [TBL] [Abstract][Full Text] [Related]
24. Para This, Fibromin That: The Role of CDC73 in Parathyroid Tumors and Familial Tumor Syndromes. Ababneh E; Nosé V Surg Pathol Clin; 2023 Mar; 16(1):97-105. PubMed ID: 36739170 [TBL] [Abstract][Full Text] [Related]
25. Phenotypic Profiling and Molecular Mechanisms in Hyperparathyroidism-jaw Tumor Syndrome. Tora R; Welch J; Sun J; Agarwal SK; Bell DA; Merino M; Weinstein LS; Simonds WF; Jha S J Clin Endocrinol Metab; 2023 Nov; 108(12):3165-3177. PubMed ID: 37339334 [TBL] [Abstract][Full Text] [Related]
26. Aberrant methylation of the HRPT2 gene in parathyroid carcinoma. Hewitt KM; Sharma PK; Samowitz W; Hobbs M Ann Otol Rhinol Laryngol; 2007 Dec; 116(12):928-33. PubMed ID: 18217513 [TBL] [Abstract][Full Text] [Related]
27. Hyperparathyroidism-jaw tumor syndrome: a report of three large kindred. Iacobone M; Masi G; Barzon L; Porzionato A; Macchi V; Ciarleglio FA; Palù G; De Caro R; Viel G; Favia G Langenbecks Arch Surg; 2009 Sep; 394(5):817-25. PubMed ID: 19529956 [TBL] [Abstract][Full Text] [Related]
31. Genome-wide and locus specific alterations in CDC73/HRPT2-mutated parathyroid tumors. Sulaiman L; Haglund F; Hashemi J; Obara T; Nordenström J; Larsson C; Juhlin CC PLoS One; 2012; 7(9):e46325. PubMed ID: 23029479 [TBL] [Abstract][Full Text] [Related]
32. A family case report of parathyroid carcinoma associated with Gu Y; Ye Y; Shu H; Chang L; Xie Y; Li F; Zhu T; Liu M; He Q Front Endocrinol (Lausanne); 2024; 15():1330185. PubMed ID: 38348418 [TBL] [Abstract][Full Text] [Related]
33. Absence of nucleolar parafibromin immunoreactivity in subsets of parathyroid malignant tumours. Juhlin CC; Haglund F; Obara T; Arnold A; Larsson C; Höög A Virchows Arch; 2011 Jul; 459(1):47-53. PubMed ID: 21221636 [TBL] [Abstract][Full Text] [Related]
35. Hyperparathyroidism 2 gene (HRPT2, CDC73) and parafibromin studies in two patients with primary hyperparathyroidism and uncertain pathological assessment. Cetani F; Pardi E; Ambrogini E; Banti C; Viacava P; Borsari S; Bilezikian JP; Pinchera A; Marcocci C J Endocrinol Invest; 2008 Oct; 31(10):900-4. PubMed ID: 19092296 [TBL] [Abstract][Full Text] [Related]
36. Analysis of aberrantly spliced HRPT2 transcripts and the resulting proteins in HPT-JT syndrome. Moon S; Kim JH; Shim JY; Ahn YB; Song KH; Cha BY; Maeng LS; Han JH Mol Genet Metab; 2010 Aug; 100(4):365-71. PubMed ID: 20541447 [TBL] [Abstract][Full Text] [Related]
37. Downregulation of CASR expression and global loss of parafibromin staining are strong negative determinants of prognosis in parathyroid carcinoma. Witteveen JE; Hamdy NA; Dekkers OM; Kievit J; van Wezel T; Teh BT; Romijn JA; Morreau H Mod Pathol; 2011 May; 24(5):688-97. PubMed ID: 21240254 [TBL] [Abstract][Full Text] [Related]
38. Molecular genetics of syndromic and non-syndromic forms of parathyroid carcinoma. Cardoso L; Stevenson M; Thakker RV Hum Mutat; 2017 Dec; 38(12):1621-1648. PubMed ID: 28881068 [TBL] [Abstract][Full Text] [Related]
39. HIGH RISK OF PARATHYROID CARCINOMA AND GENETIC SCREENING IN THE FIRST DIAGNOSED ROMANIAN FAMILY WITH HYPERPARATHYROIDISM-JAW TUMOR SYNDROME AND A GERMLINE MUTATION OF THE CDC73 GENE. Grigorie D; Sucaliuc A; Ciuffi S; Franceschelli F; Marini F; Ioachim D; Terzea D; Brandi MLL Acta Endocrinol (Buchar); 2019; 15(3):398-403. PubMed ID: 32010362 [TBL] [Abstract][Full Text] [Related]
40. Mice deleted for cell division cycle 73 gene develop parathyroid and uterine tumours: model for the hyperparathyroidism-jaw tumour syndrome. Walls GV; Stevenson M; Lines KE; Newey PJ; Reed AAC; Bowl MR; Jeyabalan J; Harding B; Bradley KJ; Manek S; Chen J; Wang P; Williams BO; Teh BT; Thakker RV Oncogene; 2017 Jul; 36(28):4025-4036. PubMed ID: 28288139 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]